Author

Nofel Mahmmod 1

1 Antonius Ziekenhuis Gastroenterology,Zeist,Netherlands

LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERA

Shannon Kanis, Sanne Modderman, Johanna Caroline Escher, Ruud Beukers, K.H.N. (Nanne) de Boer, Alexander Bodelier, ACTM Depla, Gerard Dijkstra, Anne-Baue Van Dijk, Lennard P.L. Gilissen, Frank Hoentjen, Jeroen Michiel Jansen, Johannes Kuijvenhoven, Nofel Mahmmod, R. Mallant, Andrea E. Van Der Meulen - De Jong, Anahita Noruz

PERSONALISED CARE WITH THE TELEMEDICINE TOOL MYIBDCOACH IS COST-EFFECTIVE. A COST-UTILITY ANALYSIS OF THE MYIBDCOACH TRIAL

Marin de Jong, Andrea Van der Meulen - De Jong, Marielle Romberg-Camps, Marco Becx, Jeroen P.W. Maljaars, Mia Cilissen, Ad van Bodegraven, Nofel Mahmmod, Tineke Markus, Wim Hameeteman, Gerard Dijkstra, Ad A Masclee, Annelies Boonen, Bjorn Winkens, Astrid van Tubergen, Daisy Mae Jonkers, Marieke J. Pierik

Reverse switching to originator infliximab may be considered in patients with inflammatory bowel diseases experiencing new side effects or loss of response after switching to a CT-P13 biosimilar

Shaden Mahmmod, Hans-Paul Damiaan Schultheiss, Nofel Mahmmod, Adriaan C. Tan, Gerard Dijkstra, Herma H. Fidder

Item 1 - 3 / 4
1